Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;32(8):954-963.
doi: 10.1038/s41431-024-01642-7. Epub 2024 Jun 1.

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

Affiliations

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

Maria Lisa Dentici et al. Eur J Hum Genet. 2024 Aug.

Abstract

Pathogenic, largely truncating variants in the ETS2 repressor factor (ERF) gene, encoding a transcriptional regulator negatively controlling RAS-MAPK signaling, have been associated with syndromic craniosynostosis involving various cranial sutures and Chitayat syndrome, an ultrarare condition with respiratory distress, skeletal anomalies, and facial dysmorphism. Recently, a single patient with craniosynostosis and a phenotype resembling Noonan syndrome (NS), the most common disorder among the RASopathies, was reported to carry a de novo loss-of-function variant in ERF. Here, we clinically profile 26 individuals from 15 unrelated families carrying different germline heterozygous variants in ERF and showing a phenotype reminiscent of NS. The majority of subjects presented with a variable degree of global developmental and/or language delay. Their shared facial features included absolute/relative macrocephaly, high forehead, hypertelorism, palpebral ptosis, wide nasal bridge, and low-set/posteriorly angulated ears. Stature was below the 3rd centile in two-third of the individuals, while no subject showed typical NS cardiac involvement. Notably, craniosynostosis was documented only in three unrelated individuals, while a dolichocephalic aspect of the skull in absence of any other evidence supporting a premature closing of sutures was observed in other 10 subjects. Unilateral Wilms tumor was diagnosed in one individual. Most cases were familial, indicating an overall low impact on fitness. Variants were nonsense and frameshift changes, supporting ERF haploinsufficiency. These findings provide evidence that heterozygous loss-of-function variants in ERF cause a "RASopathy" resembling NS with or without craniosynostosis, and allow a first dissection of the molecular circuits contributing to MAPK signaling pleiotropy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Facial features of the subjects carrying heterozygous truncating variants in ERF.
Note the facial gestalt suggestive of Noonan syndrome (see: high forehead, hypertelorism, palpebral ptosis, downslanted palpebral fissures, thick lips, and low-set posteriorly angulated ears). A coarse facies characterizes subject #301. Two patients (family 4, subject #402; family 6, subject #601) underwent surgical correction of craniosynostosis (lambdoid and sagittal suture, respectively).

References

    1. Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230–6. 10.1016/j.gde.2009.04.001. 10.1016/j.gde.2009.04.001 - DOI - PMC - PubMed
    1. Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann NY Acad Sci. 2010;1214:99–121. 10.1111/j.1749-6632.2010.05790.x. 10.1111/j.1749-6632.2010.05790.x - DOI - PMC - PubMed
    1. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25:161–79. 10.1016/j.beem.2010.09.002. 10.1016/j.beem.2010.09.002 - DOI - PMC - PubMed
    1. Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;26:333–42. 10.1016/S0140-6736(12)61023-X. 10.1016/S0140-6736(12)61023-X - DOI - PMC - PubMed
    1. Tartaglia M, Aoki Y, Gelb BD. The molecular genetics of RASopathies: an update on novel disease genes and new disorders. Am J Med Genet C Semin Med Genet. 2022;190:425–39. 10.1002/ajmg.c.32012. 10.1002/ajmg.c.32012 - DOI - PMC - PubMed

LinkOut - more resources